|
|
Volumn 96, Issue 19, 2004, Pages 1410-1412
|
|
Despite positive studies, popularity of chemoprevention drugs increasing slowly
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALPHA TOCOPHEROL;
CELECOXIB;
DUTASTERIDE;
FINASTERIDE;
PLACEBO;
RALOXIFENE;
ROFECOXIB;
SELENIUM;
TAMOXIFEN;
ANTIANDROGEN;
ANTINEOPLASTIC AGENT;
ANTINEOPLASTIC HORMONE AGONISTS AND ANTAGONISTS;
NONSTEROID ANTIINFLAMMATORY AGENT;
PYRAZOLE DERIVATIVE;
SULFONAMIDE;
ADENOMATOUS POLYP;
BREAST CANCER;
CANCER GRADING;
CANCER MORTALITY;
CANCER RESEARCH;
CANCER RISK;
CHEMOPROPHYLAXIS;
CLINICAL TRIAL;
COLON CANCER;
COST EFFECTIVENESS ANALYSIS;
DRUG COST;
ENDOMETRIUM CANCER;
FEMALE;
FOLLOW UP;
HIGH RISK POPULATION;
HUMAN;
LIBIDO DISORDER;
LUNG EMBOLISM;
MALE;
MALE SEXUAL DYSFUNCTION;
MEDICAL LITERATURE;
NOTE;
PRIORITY JOURNAL;
PROSTATE CANCER;
PROSTATECTOMY;
RISK BENEFIT ANALYSIS;
STROKE;
ARTICLE;
BREAST TUMOR;
CELL TRANSFORMATION;
COLON POLYPOSIS;
COST BENEFIT ANALYSIS;
DRUG EFFECT;
ECONOMICS;
NEOPLASM;
PRESCRIPTION;
PROSTATE TUMOR;
STATISTICS;
UNITED STATES;
ADENOMATOUS POLYPOSIS COLI;
ANDROGEN ANTAGONISTS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
ANTICARCINOGENIC AGENTS;
ANTINEOPLASTIC AGENTS, HORMONAL;
BREAST NEOPLASMS;
CELL TRANSFORMATION, NEOPLASTIC;
CLINICAL TRIALS;
COST-BENEFIT ANALYSIS;
FEMALE;
FINASTERIDE;
HUMANS;
MALE;
NEOPLASMS;
PRESCRIPTIONS, DRUG;
PROSTATIC NEOPLASMS;
PYRAZOLES;
SULFONAMIDES;
TAMOXIFEN;
UNITED STATES;
|
|
EID: 6944244522
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/96.19.1410 Document Type: Note |
|
Times cited : (5)
|
|
References (0)
|